Cairn Homes Plc: Transaction in Own Shares
The Company announces that on 7 January 2025 it purchased a total of 275,000 of its ordinary shares of EUR 0.001 each (the "ordinary shares") on Euronext Dublin and the London Stock Exchange through ...
ndtvprofit3h
Final Day! Indobell Insulations IPO: Check GMP, Day 3 Subscription Status, Allotment Date
Indobell Insulations IPO GMP (grey market premium) was NIL as of 7:54 a.m. on Jan. 8 pointing to a possible flat listing for ...
decrypt16h
Metis Launches DSEQ Reboot to Enhance DeFi Ecosystem with ENKI as Key Partner
The DSEQ Reboot is an effort to improve the value flow of DeFi on Metis significantly. Metis’s approach integrates ...
Positive Outlook for Viridian Therapeutics: Analyst Reaffirms Buy Rating on Strong Competitive Position and Efficacy of VRDN-001
In a report released today, Serge Belanger from Needham maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report), with a price ...
ndtvprofit1d
Indobell Insulations IPO Day 2: GMP, Subscription Status, Price Band And More
Indobell Insulations IPO GMP (grey market premium) was Rs 0 apiece on Jan. 7, indicating a flats listing. The SME issue has ...
lupus.bmj1d
Belimumab versus telitacicept in sequential treatment after rituximab for refractory lupus nephritis: a real-world multicentre study
Objective Both belimumab and telitacicept are recognised blockers for B lymphocyte activation, both of which have been ...
The American Journal of Managed Care1d
MRD Status Prior to Allo-HSCT Shows Strong Prognostic Value in AML, MDS
A study demonstrated that pre-transplant measurable residual disease (MRD) status is a strong prognostic factor for overall ...
Taiwan News1d
Algernon Pharmaceuticals Receives Notice of Allowance from USPTO For Repirinast in Kidney Disease Patent
Repirinast is the Company’s lead candidate for the treatment of CKD based on data showing it reduced fibrosis by 51% with statistical significance and showed an additive benefit to telmisartan in a ...